Negligible impact of highly patient-specific decision support for potassium-increasing drug-drug interactions – a cluster-randomised controlled trial | Zendy

Patrick E. Beeler | Zendy; Emmanuel Eschmann | Zendy; Markus Schneemann | Zendy; J�rg Blaser | Zendy

Open Access

Negligible impact of highly patient-specific decision support for potassium-increasing drug-drug interactions – a cluster-randomised controlled trial

Author(s) -

Patrick E. Beeler,

Emmanuel Eschmann,

Markus Schneemann,

J�rg Blaser

Publication year - 2019

Publication title -

schweizerische medizinische wochenschrift

Language(s) - English

Resource type - Journals

ISSN - 0036-7672

DOI - 10.4414/smw.2019.20035

Subject(s) - medicine , potassium , drug , adverse effect , intervention (counseling) , randomized controlled trial , cluster (spacecraft) , clinical trial , clinical endpoint , emergency medicine , pharmacology , nursing , chemistry , organic chemistry , computer science , programming language

A highly patient-specific CDS feature combination had a negligible impact on the management of potentially serious potassium-increasing DDIs and was unable to improve safety among hospitalised patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research